Rhinomed Limited

RHNMF · OTC
Analyze with AI
12/30/2023
6/30/2023
12/30/2022
6/30/2022
Operating Activities
Net Income$0-$6,254-$4,654-$2,031
Dep. & Amort.$0$0$0$0
Deferred Tax$0$0$0$0
Stock-Based Comp.$0$0$0$0
Change in WC$0$0$0$0
Other Non-Cash-$7,202$1,795$1,935-$1,556
Operating Cash Flow-$7,202-$4,459-$2,719-$3,587
Investing Activities
PP&E Inv.$0-$56-$39-$640
Net Acquisitions$0$0$0$0
Inv. Purchases$0$0$0$0
Inv. Sales/Matur.$0$0$0$0
Other Inv. Act.$0$0$0$0
Investing Cash Flow$0-$56-$39-$640
Financing Activities
Debt Repay.$0$0$0$0
Stock Issued$0$0$0$4,660
Stock Repurch.$0$0$0$0
Dividends Paid$0$0$0$0
Other Fin. Act.$7,524$1,064$4,401$4,605
Financing Cash Flow$7,524$1,064$4,401$4,605
Forex Effect$0$0$0$0
Net Chg. in Cash$161-$3,450$1,642$378
Supplemental Information
Beg. Cash$0$0$0$0
End Cash$161-$3,450$1,642$378
Free Cash Flow-$7,202-$4,514-$2,759-$4,227
Rhinomed Limited (RHNMF) Financial Statements & Key Stats | AlphaPilot